Common Regulatory Challenges and Market Access Barriers in Argentina – pharmacovigilance and clinical trials Common Regulatory Challenges and Market Access Barriers in Argentina – pharmacovigilance and clinical trials Argentina’s evolving regulatory landscape presents several challenges and access barriers for companies targeting the local pharmaceutical market. In particular, navigating pharmacovigilance and clinical trials can be complex for stakeholders, including regulatory affairs teams, quality assurance, pharmacovigilance, and clinical research professionals. This article aims to provide a comprehensive, step-by-step guide on understanding and addressing these challenges within the framework established by the Argentine National Administration of Drugs, Food and Medical Technology (ANMAT) and…